Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231

Background: It has been suggested that combined effect of natural products may improve the treatment effectiveness in combating proliferation of cancer cells. The present study was undertaken to evaluate the possibility that the combination of xanthorrhizol and curcumin might show synergistic growth...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheah, Yew, Nordin, Fariza, Sarip, Rozie, Tee, Thiam, Azimahtol, Hawariah, Sirat, Hasnah M., Rashid, Badrul, Abdullah, Noor, Ismail, Zakiah
Format: Article
Published: BioMed Central 2009
Subjects:
Online Access:http://eprints.utm.my/id/eprint/13264/
http://dx.doi.org/10.1186/1475-2867-9-1
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.utm.13264
record_format eprints
spelling my.utm.132642011-07-29T01:44:14Z http://eprints.utm.my/id/eprint/13264/ Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231 Cheah, Yew Nordin, Fariza Sarip, Rozie Tee, Thiam Azimahtol, Hawariah Sirat, Hasnah M. Rashid, Badrul Abdullah, Noor Ismail, Zakiah QD Chemistry RC0254 Neoplasms. Tumors. Oncology (including Cancer) Background: It has been suggested that combined effect of natural products may improve the treatment effectiveness in combating proliferation of cancer cells. The present study was undertaken to evaluate the possibility that the combination of xanthorrhizol and curcumin might show synergistic growth inhibitory effect towards MDA-MB-231 human breast cancer cells via apoptosis induction. The effective dose that produced 50% growth inhibition (GI50) was calculated from the log dose-response curve of fixed-combinations of xanthorrhizol and curcumin generated from the sulforhodamine B (SRB) assay. The experimental GI50 value was used to determine the synergistic activity of the combination treatment by isobolographic analysis and combination-index method. Further investigation of mode of cell death induced by the combination treatment was conducted in the present study. Results: Isobole analysis revealed that substances interaction was synergistic when xanthorrhizol and curcumin were added concurrently to the cultures but merely additive when they were added sequentially. The synergistic combination treatment was then applied to the cultures to investigate the mode of cell death induced by the treatment. Immunofluorescence staining using antibody MitoCapture™ revealed the possibility of altered mitochondrial transmembrane potential, which is one of the hallmark of apoptosis. Hoechst 33258 nuclear staining assay showed the rate of apoptosis of MDA-MB-231 cells to increase in response to the treatment. Apoptotic cell death was further confirmed by DNA fragmentation assay, where internucleosomal excision of DNA was induced upon treatment with xanthorrhizol-curcumin. Conclusion: This isthe first time the combined cytotoxic effect of xanthorrhizol and curcumin on MDA-MB-231 cells has been documented and our findings provide experimental support to the hypothesis that combined xanthorrhizol-curcumin showed synergistic growth inhibitory activity on MDA-MB-231 cells via apoptosis induction. BioMed Central 2009 Article PeerReviewed Cheah, Yew and Nordin, Fariza and Sarip, Rozie and Tee, Thiam and Azimahtol, Hawariah and Sirat, Hasnah M. and Rashid, Badrul and Abdullah, Noor and Ismail, Zakiah (2009) Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cancer Cell International, 9 (1). p. 1. ISSN 1475-2867 http://dx.doi.org/10.1186/1475-2867-9-1 doi:10.1186/1475-2867-9-1
institution Universiti Teknologi Malaysia
building UTM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Teknologi Malaysia
content_source UTM Institutional Repository
url_provider http://eprints.utm.my/
topic QD Chemistry
RC0254 Neoplasms. Tumors. Oncology (including Cancer)
spellingShingle QD Chemistry
RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Cheah, Yew
Nordin, Fariza
Sarip, Rozie
Tee, Thiam
Azimahtol, Hawariah
Sirat, Hasnah M.
Rashid, Badrul
Abdullah, Noor
Ismail, Zakiah
Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231
description Background: It has been suggested that combined effect of natural products may improve the treatment effectiveness in combating proliferation of cancer cells. The present study was undertaken to evaluate the possibility that the combination of xanthorrhizol and curcumin might show synergistic growth inhibitory effect towards MDA-MB-231 human breast cancer cells via apoptosis induction. The effective dose that produced 50% growth inhibition (GI50) was calculated from the log dose-response curve of fixed-combinations of xanthorrhizol and curcumin generated from the sulforhodamine B (SRB) assay. The experimental GI50 value was used to determine the synergistic activity of the combination treatment by isobolographic analysis and combination-index method. Further investigation of mode of cell death induced by the combination treatment was conducted in the present study. Results: Isobole analysis revealed that substances interaction was synergistic when xanthorrhizol and curcumin were added concurrently to the cultures but merely additive when they were added sequentially. The synergistic combination treatment was then applied to the cultures to investigate the mode of cell death induced by the treatment. Immunofluorescence staining using antibody MitoCapture™ revealed the possibility of altered mitochondrial transmembrane potential, which is one of the hallmark of apoptosis. Hoechst 33258 nuclear staining assay showed the rate of apoptosis of MDA-MB-231 cells to increase in response to the treatment. Apoptotic cell death was further confirmed by DNA fragmentation assay, where internucleosomal excision of DNA was induced upon treatment with xanthorrhizol-curcumin. Conclusion: This isthe first time the combined cytotoxic effect of xanthorrhizol and curcumin on MDA-MB-231 cells has been documented and our findings provide experimental support to the hypothesis that combined xanthorrhizol-curcumin showed synergistic growth inhibitory activity on MDA-MB-231 cells via apoptosis induction.
format Article
author Cheah, Yew
Nordin, Fariza
Sarip, Rozie
Tee, Thiam
Azimahtol, Hawariah
Sirat, Hasnah M.
Rashid, Badrul
Abdullah, Noor
Ismail, Zakiah
author_facet Cheah, Yew
Nordin, Fariza
Sarip, Rozie
Tee, Thiam
Azimahtol, Hawariah
Sirat, Hasnah M.
Rashid, Badrul
Abdullah, Noor
Ismail, Zakiah
author_sort Cheah, Yew
title Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231
title_short Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231
title_full Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231
title_fullStr Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231
title_full_unstemmed Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231
title_sort combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells mda-mb-231
publisher BioMed Central
publishDate 2009
url http://eprints.utm.my/id/eprint/13264/
http://dx.doi.org/10.1186/1475-2867-9-1
_version_ 1643646151874838528
score 13.160551